The Paradox of Protection
In the time it takes to read this sentence, roughly 500 children worldwide receive a life-saving vaccine. Many carry the branding of Western giants, yet the doses that reach the Global South are overwhelmingly produced by manufacturers in India and China. This is not a flaw in the system—it is the system: a carefully balanced architecture of high-margin innovation in the West and high-volume affordability in the South.
The global vaccine market hit approximately $82 billion in 2025 (Cognitive Market Research, December 2025 update). While commercial estimates capture premium pricing in high-income markets, the WHO’s 2025 Global Vaccine Market Report (data for 2024) records a “financial value” of $66.5 billion across 7.2 billion doses—highlighting the stark reality of tiered pricing that makes vaccines accessible where they are needed most.
Free Membership Required
You must be a Free member to access this content.
